Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses

Real-world Performance of Meta-analysis Methods for Double-Zero-Event Studies with Dichotomous Outcomes Using the Cochrane Database of Systematic Reviews

(2019) Yanan Ren et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Harms are assessed inconsistently and reported inadequately Part 1: Systematic adverse events

(2019) Evan Mayo-Wilson et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Retrieval of individual patient data depended on study characteristics: a randomized controlled trial

(2019) Areti Angeliki Veroniki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

A comparison of seven random-effects models for meta-analyses that estimate the summary odds ratio

(2018) Dan Jackson et al.   STATISTICS IN MEDICINE

Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published inThe BMJandPLOS Medicine

(2018) Florian Naudet et al.   BMJ-British Medical Journal

Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published inThe BMJandPLOS Medicine

(2018) Florian Naudet et al.   BMJ-British Medical Journal

Overview and experience of the YODA Project with clinical trial data sharing after 5 years

(2018) Joseph S. Ross et al.   Scientific Data

Implications of Removing Rosiglitazone’s Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes

(2018) Ryan P. Hickson et al.   Journal of Managed Care & Specialty Pharmacy

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy

(2017) Evan Mayo-Wilson et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Whose Data Are They Anyway? Can a Patient Perspective Advance the Data-Sharing Debate?

(2017) Charlotte J. Haug   NEW ENGLAND JOURNAL OF MEDICINE

Practical guidance for using multiple data sources in systematic reviews and meta-analyses (with examples from the MUDS study)

(2017) Evan Mayo-Wilson et al.   Research Synthesis Methods

Supporting open access to clinical trial data for researchers: The Duke Clinical Research Institute–Bristol-Myers Squibb Supporting Open Access to Researchers Initiative

(2016) Michael J. Pencina et al.   AMERICAN HEART JOURNAL

Research methods to change clinical practice for patients with rare cancers

(2016) Lucinda Billingham et al.   LANCET ONCOLOGY

Challenges for Sharing Data from Embedded Research

(2016) Richard Platt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Toward Fairness in Data Sharing

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

The Yale Open Data Access (YODA) Project — A Mechanism for Data Sharing

(2016) Harlan M. Krumholz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recognizing Data Generation

(2016) Mette Kalager et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ

(2016) Danielle L. Burke et al.   STATISTICS IN MEDICINE

Meta-analysis of clinical trials with rare events

(2015) Dankmar Böhning et al.   BIOMETRICAL JOURNAL

Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data

(2015) Lesley A. Stewart et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Use of Antidiabetic Drugs in the U.S., 2003–2012

(2014) Christian Hampp et al.   DIABETES CARE

Increasing value and reducing waste in research design, conduct, and analysis

(2014) John P A Ioannidis et al.   LANCET

Ushering in a New Era of Open Science Through Data Sharing

(2013) Joseph S. Ross et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Access to Patient-Level Data from GlaxoSmithKline Clinical Trials

(2013) Perry Nisen et al.   NEW ENGLAND JOURNAL OF MEDICINE

US regulators relax restrictions on rosiglitazone

(2013) M. McCarthy   BMJ-British Medical Journal

A Model for Dissemination and Independent Analysis of Industry Data

(2011) Harlan M. Krumholz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rosiglitazone Revisited

(2010) Steven E. Nissen et al.   ARCHIVES OF INTERNAL MEDICINE

The rise and fall of rosiglitazone

(2010) S. E. Nissen   EUROPEAN HEART JOURNAL

Ensuring Integrity in Industry-Sponsored Research

(2010) Catherine D. DeAngelis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Setting the RECORD Straight

(2010) Steven E. Nissen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone

(2010) Nilay D. Shah et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regulatory Action on Rosiglitazone by the U.S. Food and Drug Administration

(2010) Janet Woodcock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Revisiting the Rosiglitazone Story — Lessons Learned

(2010) Clifford J. Rosen   NEW ENGLAND JOURNAL OF MEDICINE

Meta-analysis for rare events

(2010) Tianxi Cai et al.   STATISTICS IN MEDICINE

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

(2009)   ARCHIVES OF INTERNAL MEDICINE

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes

(2009) John Dormandy et al.   DRUG SAFETY

Cardiac safety profile of rosiglitazone

(2009) Edoardo Mannucci et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction

(2008) L. Tian et al.   BIOSTATISTICS

Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone

(2008) Issa J Dahabreh   Clinical Trials

The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment

(2008) Robert M. Califf et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY